Yang Y, Ding L, Li S
Institute of Basic Medical Sciences, CAMS, Beijing.
Proc Chin Acad Med Sci Peking Union Med Coll. 1990;5(1):13-8.
The changes of carbamyl phosphate synthetase I (CPS 1) in diethylnitrosamine-(DEN)-induced enzyme-altered liver cells were studied by means of immunohistochemical (PAP) and in situ cDNA-mRNA hybridization methods. The experimental rats were treated with DEN, 2-acetylaminofluorene (2-AAF) and 2/3 hepatectomy according to Solt-Farber's protocol and were further promoted by oral daily administration of 0.05% phenobarbital in drinking water. The results showed that the average number of lesions showing abnormal expression of CPS 1 was relatively constant over the course of the experiment (8 months), while the number of normally expressing lesions gradually decreased. The former lesions were also larger in volume than the latter ones. We conclude that in DEN-initiated lesions the abnormally expressed CPS 1 lesions may grow continuously, thus leading to the formation of larger nodules. We also suspect that some of these lesions have increased tendencies to develop into tumors.
采用免疫组织化学(PAP)法和原位cDNA-mRNA杂交法,研究了二乙基亚硝胺(DEN)诱导的酶改变肝细胞中氨甲酰磷酸合成酶I(CPS 1)的变化。按照索尔特-法伯方案,给实验大鼠注射DEN、2-乙酰氨基芴(2-AAF)并进行2/3肝切除术,然后通过每日在饮用水中口服0.05%苯巴比妥进一步促进。结果显示,在实验过程(8个月)中,显示CPS 1异常表达的病变平均数量相对恒定,而正常表达病变的数量逐渐减少。前者病变的体积也比后者大。我们得出结论,在DEN引发的病变中,异常表达CPS 1的病变可能持续生长,从而导致更大结节的形成。我们还怀疑其中一些病变发展为肿瘤的倾向增加。